Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.2 to v3.6.3. This indicates a minor update to the page or its assets rather than a change to core content and user-facing features.
    Difference
    0.0%
    Check dated 2026-07-03T21:44:59.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, indicating a minor build update. This update does not modify the study details or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-06-26T20:16:49.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page adds new navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows recruitment is closed. It also standardizes the Intervention/Treatment heading and updates the site revision from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T10:59:12.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The study record was updated to Terminated and now includes a new Strategic considerations section; the Petah Tikva location was broadened to include the Central District, and enrollment dates moved from estimated to actual, with a new revision timestamp.
    Difference
    0.7%
    Check dated 2026-06-05T08:29:45.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous revision tag. This reflects a system-level update to the page without altering the study information.
    Difference
    0.0%
    Check dated 2026-05-15T05:43:59.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The Taiwan site entry was updated from Taoyuan, Taiwan, 333 to Taoyuan City, Taiwan, 333, clarifying the exact city for this enrollment site. This change improves precision in the study's location listing for Taiwan.
    Difference
    0.0%
    Check dated 2026-05-08T09:28:57.000Z thumbnail image

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.